As discussed above, insulin resistance and hyperinsulinemia increase the levels of intracellular and extracellular Aβ, resulting in Aβ accumulation and abnormal tau phosphorylation via the insulin-signaling activation of the GSK-3b cascade [92]. The gene discussed is MAPT; the disease is hyperinsulinism.